AdaptHealth closes infusion asset sale, reduces debt by $65M, updates FY2025 guidance

AdaptHealth Corp.

Closed disposition of certain infusion assets in Wellness at Home segment; assets had ~$52M annual revenue and ~$5M annual Adjusted EBITDA.
Used proceeds for $65M term loan prepayment; cumulative $135M debt reduction (including $70M prepayment in May).
Revised FY2025 guidance: revenue $3,150M-$3,290M; Adjusted EBITDA $662M-$702M; Free Cash Flow $170M-$190M.
Company expects $30M cash taxes on gains from this disposition.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.